Select all docs (Max 200)
Narrow Results:
Publication Year
Medical Subject
- Abnormalities, Drug-Induced 1
- Administration, Intravenous 1
- Adolescent 5
- Adult 11
- Adverse Drug Reaction Reporting Systems 1
- Adverse reactions 1
- Aerosols 4
- Aged 3
- Aged, 80 and over 3
- Anaphylaxis 1
- Animal Diseases/Epidemiology 1
- Animal Diseases/History 1
- Animal Diseases/Microbiology 1
- Animals 8
- Animals, Wild 1
- Anthrax 12
- Anthrax/diagnosis 1
- Anthrax / drug therapy 1
- Anthrax/drug therapy 1
- Anthrax/Epidemiology 2
- Anthrax/epidemiology 1
- Anthrax/History 2
- Anthrax/Microbiology 1
- Anthrax / prevention & control 3
- Anthrax/prevention & control 3
- Anthrax/Transmission 1
- Anthrax/transmission 1
- Anthrax Vaccines 8
- Anthrax Vaccines / administration & dosage 1
- Anthrax Vaccines / adverse effects 1
- Anthrax Vaccines / contraindications 1
- Anthrax Vaccines 3
- Anti-Bacterial Agents 4
- Anti-HIV Agents / therapeutic use 1
- Anti-Infective Agents 4
- Anti-Infective Agents/adverse effects 1
- Anti-Infective Agents/therapeutic use 1
- Antibiotic Prophylaxis 2
- Antibodies, Monoclonal 1
- Antigens, Bacterial 2
- Antigens, Viral/Analysis 1
- Antitoxins 5
- Aromatherapy 2
- Article 4
- Bacillus anthracis 9
- Bacillus Anthracis 5
- Bacillus cereus 1
- Bacterial Toxins 1
- Base Sequence 1
- Biological Warfare Agents 1
- Bioterrorism 3
- Blood-Borne Pathogens 1
- Brain 1
- Burkholderia pseudomallei 4
- Burkholderia Pseudomallei 2
- Capacity Building 1
- Case-Control Studies 1
- Cattle 1
- Cattle Diseases 1
- Centers for Disease Control and Prevention, U.S. 2
- Child 8
- Child, Preschool 5
- Ciprofloxacin 2
- CoronaVirus Infections 2
- COVID-19 3
- COVID-19 / Prevention & Control 1
- COVID-19 Serological Testing 1
- COVID-19 Testing 1
- COVID-19 Vaccines 1
- COVID-19 Vaccines/Administration & Dosage 1
- Diagnostic Tests, Routine 2
- Disease Outbreaks 10
- Doxycycline 2
- Drug Therapy, Combination 3
- Early Diagnosis 2
- Emergencies 2
- Epidemics 2
- Female 14
- Full Report 3
- Hepatitis C 2
- History, 21St Century 2
- Humans 28
- Immunoglobulin G 2
- Infant 3
- Infant, Newborn 2
- Male 8
- Mass Casualty Incidents 3
- Melioidosis 4
- Meningitis 3
- Middle Aged 6
- Occupational Exposure 3
- Pregnancy 7
- Pregnancy Complications, Infectious 3
- Public Health 2
- Research 3
- Respiratory Tract Infections 3
- Survival Analysis 2
- Time Factors 2
- United States 7
- Young Adult 4
Personal Author
-
Bower, William A. (44)
Corporate Author
- AAP COMMITTEE ON INFECTIOUS DISEASES and DISASTER PREPAREDNESS ADVISORY COUNCIL 1
- Arizona. Department of Health Services. 1
- Beth Israel Deaconess Medical Center. 3
- CDC COVID-9 Response Team. 2
- Centers for Disease Control and Prevention (U.S.) 2
- Centers for Disease Control and Prevention (U.S.)Epidemic Intelligence Service. 1
- Centers for Diseases Control and Prevention (U.S.) 1
- High-Consequence Pathogens and Pathology. 1
- National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Division of High-Consequence Pathogens and Pathology. 10
- National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Division of High-Consequence Pathogens and Pathology. Bacterial Special Pathogens Branch. 1
- National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Division of Preparedness and Emerging Infections. 4
- National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Office of the Director. 1
- National Center for HIV, STD, and TB Prevention (U.S.) 1
- National Center for Infectious Diseases (U.S.) 1
- National Center on Birth Defects and Developmental Disabilities (Centers for Disease Control and Prevention). Division of Birth Defects and Infant Disorders. 3
- National Center on Birth Defects and Developmental Disabilities (Centers for Disease Control and Prevention). Division of Human Development and Disability. 3
- National Institute for Occupational Safety and Health. Division of Surveillance, Hazard Evaluations, and Field Studies. 1
- Pima County (Ariz.). Health Department. 1
- U.S. Zika Pregnancy Registry Collaboration 1
- United States. Advisory Committee on Immunization Practices. 1
- United States. Advisory Committee on Immunization Practices. Anthrax Vaccine Work Group. 6
- United States Food and Drug Administration. 1
- University of California San Diego School of Medicine. 3
- University of Florida College of Pharmacy. 3
- University of Utah School of Medicine. 3
- Workgroup on Anthrax Clinical Guidelines. 1
- Zika Virus Response Epidemiology and Surveillance Task Force Pathology Team 1
Place as Subject
- Arizona 3
- Bangladesh 1
- District of Columbia 1
- Ethiopia 1
- Georgia (Republic) 1
- Ghana 2
- India 1
- Louisiana 1
- Micronesia 1
- Namibia 1
- Puerto Rico 1
- Scotland 1
- Texas 4
- Thailand 1
- United States 13
Resource Type General
Resource Type Specific
Keywords
Diseases And Conditions
Select all docs (Max 200)
41 -
44 of 44 Results
SELECT A RANGE
SELECT A FORMAT
Refine Results
Refine Results:
- Abnormalities, Drug-Induced (1)
- Administration, Intravenous (1)
- Adolescent (5)
- Adult (11)
- Adverse Drug Reaction Reporting Systems (1)
- Adverse reactions (1)
- Aerosols (4)
- Aged (3)
- Aged, 80 and over (3)
- Anaphylaxis (1)
- Animal Diseases/Epidemiology (1)
- Animal Diseases/History (1)
- Animal Diseases/Microbiology (1)
- Animals (8)
- Animals, Wild (1)
- Anthrax (12)
- Anthrax/diagnosis (1)
- Anthrax / drug therapy (1)
- Anthrax/drug therapy (1)
- Anthrax/Epidemiology (2)
- Anthrax/epidemiology (1)
- Anthrax/History (2)
- Anthrax/Microbiology (1)
- Anthrax / prevention & control (3)
- Anthrax/prevention & control (3)
- Anthrax/Transmission (1)
- Anthrax/transmission (1)
- Anthrax Vaccines (8)
- Anthrax Vaccines / administration & dosage (1)
- Anthrax Vaccines / adverse effects (1)
- Anthrax Vaccines / contraindications (1)
- Anthrax Vaccines (3)
- Anti-Bacterial Agents (4)
- Anti-HIV Agents / therapeutic use (1)
- Anti-Infective Agents (4)
- Anti-Infective Agents/adverse effects (1)
- Anti-Infective Agents/therapeutic use (1)
- Antibiotic Prophylaxis (2)
- Antibodies, Monoclonal (1)
- Antigens, Bacterial (2)
- Antigens, Viral/Analysis (1)
- Antitoxins (5)
- Aromatherapy (2)
- Article (4)
- Bacillus anthracis (9)
- Bacillus Anthracis (5)
- Bacillus cereus (1)
- Bacterial Toxins (1)
- Base Sequence (1)
- Biological Warfare Agents (1)
- Bioterrorism (3)
- Blood-Borne Pathogens (1)
- Brain (1)
- Burkholderia pseudomallei (4)
- Burkholderia Pseudomallei (2)
- Capacity Building (1)
- Case-Control Studies (1)
- Cattle (1)
- Cattle Diseases (1)
- Centers for Disease Control and Prevention, U.S. (2)
- Child (8)
- Child, Preschool (5)
- Ciprofloxacin (2)
- CoronaVirus Infections (2)
- COVID-19 (3)
- COVID-19 / Prevention & Control (1)
- COVID-19 Serological Testing (1)
- COVID-19 Testing (1)
- COVID-19 Vaccines (1)
- COVID-19 Vaccines/Administration & Dosage (1)
- Diagnostic Tests, Routine (2)
- Disease Outbreaks (10)
- Doxycycline (2)
- Drug Therapy, Combination (3)
- Early Diagnosis (2)
- Emergencies (2)
- Epidemics (2)
- Female (14)
- Full Report (3)
- Hepatitis C (2)
- History, 21St Century (2)
- Humans (28)
- Immunoglobulin G (2)
- Infant (3)
- Infant, Newborn (2)
- Male (8)
- Mass Casualty Incidents (3)
- Melioidosis (4)
- Meningitis (3)
- Middle Aged (6)
- Occupational Exposure (3)
- Pregnancy (7)
- Pregnancy Complications, Infectious (3)
- Public Health (2)
- Research (3)
- Respiratory Tract Infections (3)
- Survival Analysis (2)
- Time Factors (2)
- United States (7)
- Young Adult (4)
-
Bower, William (44)
- AAP COMMITTEE ON INFECTIOUS DISEASES and DISASTER PREPAREDNESS ADVISORY COUNCIL (1)
- Arizona. Department of Health Services. (1)
- Beth Israel Deaconess Medical Center. (3)
- CDC COVID-9 Response Team. (2)
- Centers for Disease Control and Prevention (U.S.) (2)
- Centers for Disease Control and Prevention (U.S.)Epidemic Intelligence Service. (1)
- Centers for Diseases Control and Prevention (U.S.) (1)
- High-Consequence Pathogens and Pathology. (1)
- National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Division of High-Consequence Pathogens and Pathology. (10)
- National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Division of High-Consequence Pathogens and Pathology. Bacterial Special Pathogens Branch. (1)
- National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Division of Preparedness and Emerging Infections. (4)
- National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Office of the Director. (1)
- National Center for HIV, STD, and TB Prevention (U.S.) (1)
- National Center for Infectious Diseases (U.S.) (1)
- National Center on Birth Defects and Developmental Disabilities (Centers for Disease Control and Prevention). Division of Birth Defects and Infant Disorders. (3)
- National Center on Birth Defects and Developmental Disabilities (Centers for Disease Control and Prevention). Division of Human Development and Disability. (3)
- National Institute for Occupational Safety and Health. Division of Surveillance, Hazard Evaluations, and Field Studies. (1)
- Pima County (Ariz.). Health Department. (1)
- U.S. Zika Pregnancy Registry Collaboration (1)
- United States. Advisory Committee on Immunization Practices. (1)
- United States. Advisory Committee on Immunization Practices. Anthrax Vaccine Work Group. (6)
- United States Food and Drug Administration. (1)
- University of California San Diego School of Medicine. (3)
- University of Florida College of Pharmacy. (3)
- University of Utah School of Medicine. (3)
- Workgroup on Anthrax Clinical Guidelines. (1)
- Zika Virus Response Epidemiology and Surveillance Task Force Pathology Team (1)
- :Bower, William A. ;Yu, Yon11 17 2023 | Recommendations and Reports: Morbidity and Mortality Weekly Report (MMWR):This report updates previous CDC guidelines and recommendations on preferred prevention and treatment regimens regarding naturally occurring anthrax. ...
- :Bower, William A. ;Yu, Yon11/17/2023 | Recommendations and Reports: Morbidity and Mortality Weekly Report (MMWR):This report updates previous cdc guidelines and recommendations on preferred prevention and treatment regimens regarding naturally occurring anthrax. ...
- :Bower, William A. ;Yu, Yon06/19/2024 | Recommendations and Reports: Morbidity and Mortality Weekly Report (MMWR):This is the correction of the report published 11/17/2023Bower WA, Yu Y, Person MK, et al. CDC Guidelines for the Prevention and Treatment of Anthrax,...
- :Alter, Miriam J. ;Alvarado-Ramy, FranciscoJune 29, 2001 | Recommendations and Reports: Morbidity and Mortality Weekly Report (MMWR):This report updates and consolidates all previous U.S. Public Health Service recommendations for the management of health-care personnel (HCP) who hav...:superseded
Exit Notification/Disclaimer Policy
Links with this icon indicate that you are leaving the CDC website.
- The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
- Linking to a non-federal Website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
- You will be subject to the destination website's privacy policy when you follow the link.
- CDC is not responsible for Section 508 compliance (accessibility) on other federal or private websites.